Amgen | مبيعات



Sales تغيير تاريخ
AbbVie USD 13.34B 1.76B 2025-03
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
ALKERMES USD 390.7M 84.2M 2025-06
Amgen USD 8.15B 936M 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Exelixis USD 568.3M 12.9M 2025-06
Genmab DKK 5.28B 59.13B 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
Glaxosmithkline GBP 8.12B 105M 2024-12
Incyte USD 1.06B 10M 2025-06
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
J&J USD 23.74B 1.85B 2025-06
Merck USD 15.81B 280M 2025-06
Moderna USD 108M 858M 2025-03
Neurocrine Biosciences USD 572.6M 55.1M 2025-03
Novartis USD 14.05B 821M 2025-06
Novartis USD 13.56B 386M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
PTC Therapeutics USD 190M 23.17M 2025-03
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.9B 660M 2025-03
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
Takeda JPY 1.05T 90B 2025-03
Teva Pharmaceutical Industries USD 14.06B 1.27B 2025-03
Ultragenyx Pharmaceutical USD 139.29M 25.59M 2025-03
Vertex Pharmaceuticals USD 2.77B 142M 2025-03


Amgen مبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.